IHS Markit Life Sciences Briefing - Tokyo

alt text

Monday, May 09, 2016

    • 1:00 pmRegistration
    • 1:30 pmGlobal Context of Market Access Risk

      Gustav Ando, Vice President, IHS Life Sciences

      An overview of evolving global trends in pharmaceutical market access

    • 2:15 pmChina's Healthcare Reform Overview - Drivers and Challenges for Foreign Players

      Gustav Ando, Vice President, IHS Life Sciences
      Sophie Cairns, Senior Analyst, IHS Life Sciences

      A discussion of the implications of China’s national Healthcare reforms and what it means for multinational pharma

    • 3:15 pmCoffee Break
    • 3:30 pmHTA - A Growth Catalyst or a Time bomb for Market Access

      Sophie Cairns, Senior Analyst, IHS Life Sciences

      What does the introduction of Health Technology Assessment (HTA) mean for Japan’s pharmaceutical sector? A discussion of the implications of the growing importance of cost-effectiveness criteria for market access in Japan.

    • 4:15 pmNetworking
Filter Sort